(Q37863975)

English

Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection

scientific article published on 22 August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

0 references

Chlamydia muridarum

object named as

Chlamydia muridarum

1 reference

based on heuristic

inferred from title

author name string

Kathryn A Skelding

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Danica K Hickey

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Jay C Horvat

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Shisan Bao

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Kathryn G Roberts

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Jane M Finnie

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Philip M Hansbro

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Kenneth W Beagley

8

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

0 references

publication date

22 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

355-366

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Chlamydiae as pathogens: new species and new issues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydia pneumoniae sp. nov. for Chlamydia sp. Strain TWAR

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus...

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Infiltration of the brain by pathogens causes Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydia pneumoniae and the lung

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Role of atypical bacterial infection of the lung in predisposition/protection of asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Infections caused by Chlamydia pneumoniae strain TWAR

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydia pneumoniae, strain TWAR, as the cause of an outbreak in a boys' school previously called psittacosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Asthma. From bronchoconstriction to airways inflammation and remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydia pneumoniae, asthma, and COPD: what is the evidence?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydia pneumoniae and COPD exacerbation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Potential infectious etiologies of atherosclerosis: a multifactorial perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydia pneumoniae-induced atherosclerosis in a rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

The intracellular life of chlamydiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydial persistence: beyond the biphasic paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Skin immunization made possible by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Fc receptor regulation of protective immunity against Chlamydia trachomatis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Lung mucosal immunity: immunoglobulin-A revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Intracellular neutralization of virus by immunoglobulin A antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.104

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.07.104

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37863975&oldid=1795462365"